Northwire Canada EditionWednesday, August 5, 2026
Sign inSubscribe
Northwire
⌕
LTH 0.470 −7.8% APN 0.020 +0.0% ARTG 35.10 +4.3% STND 0.075 −11.8% AAZ 0.040 +14.3% LIFT 3.33 +0.6% LIB 0.810 +1.2% PEMC 0.050 +11.1% ELE 23.49 +7.5% AMCO 0.210 +2.4% TGOL 0.115 +9.5% SSRM 37.45 +4.5% SALT 1.51 +9.4% MON 0.650 +12.1% AZS 0.610 +28.4% NIO 0.140 +7.7% LTH 0.470 −7.8% APN 0.020 +0.0% ARTG 35.10 +4.3% STND 0.075 −11.8% AAZ 0.040 +14.3% LIFT 3.33 +0.6% LIB 0.810 +1.2% PEMC 0.050 +11.1% ELE 23.49 +7.5% AMCO 0.210 +2.4% TGOL 0.115 +9.5% SSRM 37.45 +4.5% SALT 1.51 +9.4% MON 0.650 +12.1% AZS 0.610 +28.4% NIO 0.140 +7.7%
M&A / Property

Theratechnologies acquiror Future Pak holds 100% shares

By The Northwire Desk — AI Analysis Oct 01, 2025 · 11:30 TH · 4.70 Theratechnologies Inc
TH · Price

Executive Summary

  • Theratechnologies Inc. was acquired 100 % by CB Biotechnology LLC (controlled by Future Pak LLC) under a Quebec Business Corporations Act plan of arrangement.
  • Purchase price: US$3.01 per share in cash plus one contingent value right (CVR) per share, potentially worth up to an additional US$1.19 per CVR upon achievement of milestones.
  • The fair market value of each CVR was independently valued at US$0.80 as of September 24 2025.

Key Details

  • Acquisition Structure: CB Biotechnology LLC, acting through CB, acquired all issued and outstanding common shares of Theratechnologies Inc. via a plan of arrangement approved on September 25 2025.
  • Consideration per Share: US$3.01 cash plus one CVR per share (contingent additional payment up to US$1.19 per CVR).
  • CVR Terms: Each CVR entitles the holder to aggregate payments from CB of up to US$1.19 if specified milestones are met by Theratechnologies; CVRs are administered by Computershare Trust Company of Canada.
  • Independent Valuation: Third‑party valuator determined fair market value of each CVR at US$0.80 on September 24 2025.
  • Ownership Post‑Transaction: The acquiror now controls 45,980,019 shares, representing 100 % of Theratechnologies’ issued and outstanding common stock.
  • Regulatory Filing: Early warning report filed pursuant to National Instrument 62‑103 (Early Warning System) to disclose the acquisition of securities.

Notable Quotes

(No quotes were provided in the release.)

Read the original news release →